申请人:Steinmetzer Torsten
公开号:US20100022781A1
公开(公告)日:2010-01-28
The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrien, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive.
该发明涉及一般式(I)的胰蛋白酶样丝氨酸蛋白酶抑制剂,除了抑制纤溶酶外,还抑制血浆激肽原,以及它们的制备和用作药物,优选用于治疗失血,特别是在高纤溶状态、器官移植或心脏手术干预,特别是心肺转流手术中,或作为纤维蛋白粘合剂的组分。